Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simron Singh

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 1, 2022
Incident Cancer Detection During the COVID-19 PandemicAntoine Eskander, Qing Li, Jiayue Yu, et al.
JAMA Network Open|January 10, 2023
Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in CanadaRui Fu, Rinku Sutradhar, Qing Li, et al.
Cancer Medicine|March 31, 2023
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the EarthquakeRui Fu, Rinku Sutradhar, Qing Li, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
Journal of the National Cancer Institute|May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meetingSimron Singh, Thomas A Hope, Emily B Bergsland, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed SurgeriesAntoine Eskander, Qing Li, Jiayue Yu, et al.
JAMA Network Open|April 25, 2022
Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 PandemicMeghan J Walker, Jonathan Wang, Joshua Mazuryk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineJaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
JCO Oncology Practice|May 9, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineKimberly Perez, Jaydira Del Rivero, Erin B Kennedy, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Journal of the National Comprehensive Cancer Network : JNCCN|February 1, 2022
Incident Cancer Detection During the COVID-19 PandemicAntoine Eskander, Qing Li, Jiayue Yu, et al.
JAMA Network Open|January 10, 2023
Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in CanadaRui Fu, Rinku Sutradhar, Qing Li, et al.
Cancer Medicine|March 31, 2023
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the EarthquakeRui Fu, Rinku Sutradhar, Qing Li, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
Journal of the National Cancer Institute|May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meetingSimron Singh, Thomas A Hope, Emily B Bergsland, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed SurgeriesAntoine Eskander, Qing Li, Jiayue Yu, et al.
JAMA Network Open|April 25, 2022
Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 PandemicMeghan J Walker, Jonathan Wang, Joshua Mazuryk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineJaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
JCO Oncology Practice|May 9, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineKimberly Perez, Jaydira Del Rivero, Erin B Kennedy, et al.
Pageof 15